Time Limit Dooms Nexium Antitrust Claims, AstraZeneca Says
AstraZeneca PLC and Ranbaxy Inc. filed for partial summary judgment Tuesday in multidistrict litigation alleging the companies violated antitrust laws by agreeing to delay entry of a generic version of AstraZeneca's...To view the full article, register now.
Already a subscriber? Click here to view full article